A bill for an act relating to insurance coverage for prescription insulin drugs.

This bill (SF 2322) requires most health insurance plans in Iowa to cap out-of-pocket costs for prescription insulin at $35 per prescription for up to a 31-day supply. It directly affects diabetes patients covered by health insurance plans that include prescription drug coverage, limiting their cost-sharing for four types of insulin: rapid-acting, short-acting, intermediate-acting, and long-acting. The cap applies to any covered insulin prescribed as medically necessary by a healthcare provider, though insurers may choose to set lower cost-sharing amounts. The rule takes effect for plans issued or renewed on or after January 1, 2027, and excludes certain specialized insurance types like Medicare supplements.